Michael D. Bright

904 total citations
12 papers, 589 citations indexed

About

Michael D. Bright is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Michael D. Bright has authored 12 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cell Biology and 2 papers in Epidemiology. Recurrent topics in Michael D. Bright's work include Endoplasmic Reticulum Stress and Disease (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Michael D. Bright is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Michael D. Bright collaborates with scholars based in United Kingdom, United States and Australia. Michael D. Bright's co-authors include Gad Frankel, Keith S. Robinson, Sau Fung Lee, Diana Munera, Elizabeth L. Hartland, Jaclyn S. Pearson, Faith E. Davies, Gareth J. Morgan, Anne J. Ridley and Paul Workman and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Clinical Cancer Research.

In The Last Decade

Michael D. Bright

12 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Bright United Kingdom 10 292 224 131 122 88 12 589
Iulia A. Kovari United States 15 639 2.2× 60 0.3× 155 1.2× 60 0.5× 231 2.6× 33 1.1k
Tanusree Sengupta India 11 136 0.5× 96 0.4× 49 0.4× 53 0.4× 22 0.3× 26 363
Cecelia L. Green United States 4 409 1.4× 52 0.2× 24 0.2× 146 1.2× 53 0.6× 5 590
Ismael Secundino United States 7 210 0.7× 46 0.2× 47 0.4× 25 0.2× 34 0.4× 10 412
H Furukawa Japan 11 220 0.8× 51 0.2× 35 0.3× 19 0.2× 144 1.6× 30 475
Peter Conradt Germany 15 155 0.5× 40 0.2× 135 1.0× 22 0.2× 49 0.6× 20 685
Momka Bratoeva United States 10 257 0.9× 51 0.2× 42 0.3× 53 0.4× 20 0.2× 19 423
Sang Won Hyun United States 18 535 1.8× 29 0.1× 33 0.3× 127 1.0× 47 0.5× 28 875
E Li United States 13 352 1.2× 24 0.1× 385 2.9× 104 0.9× 60 0.7× 16 793
Emanuel Smeds Sweden 16 499 1.7× 14 0.1× 249 1.9× 198 1.6× 40 0.5× 24 788

Countries citing papers authored by Michael D. Bright

Since Specialization
Citations

This map shows the geographic impact of Michael D. Bright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Bright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Bright more than expected).

Fields of papers citing papers by Michael D. Bright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Bright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Bright. The network helps show where Michael D. Bright may publish in the future.

Co-authorship network of co-authors of Michael D. Bright

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Bright. A scholar is included among the top collaborators of Michael D. Bright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Bright. Michael D. Bright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tajadura‐Ortega, Virginia, Ritu Garg, Richard Allen, et al.. (2018). An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration. BMC Biology. 16(1). 29–29. 27 indexed citations
2.
Bright, Michael D., Paul A. Clarke, Paul Workman, & Faith E. Davies. (2018). Oncogenic RAC1 and NRAS drive resistance to endoplasmic reticulum stress through MEK/ERK signalling. Cellular Signalling. 44. 127–137. 19 indexed citations
3.
Fok, Jacqueline H. L., Somaieh Hedayat, Lei Zhang, et al.. (2018). HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target. Clinical Cancer Research. 24(10). 2395–2407. 41 indexed citations
4.
Pawlyn, Charlotte, Michael D. Bright, Amy Buros, et al.. (2017). Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control. Blood Cancer Journal. 7(3). e549–e549. 81 indexed citations
5.
Pawlyn, Charlotte, Michael D. Bright, Amy Buros, et al.. (2016). Inhibition of the Epigenetic Modifier EZH2 Upregulates Cell Cycle Control Genes to Inhibit Myeloma Cell Growth and Overcome High-Risk Disease Features. Blood. 128(22). 3289–3289. 2 indexed citations
6.
Bright, Michael D., Daniel N. Itzhak, Christopher P. Wardell, Gareth J. Morgan, & Faith E. Davies. (2015). Cleavage of BLOC1S1 mRNA by IRE1 Is Sequence Specific, Temporally Separate from XBP1 Splicing, and Dispensable for Cell Viability under Acute Endoplasmic Reticulum Stress. Molecular and Cellular Biology. 35(12). 2186–2202. 44 indexed citations
7.
Itzhak, Daniel N., Michael D. Bright, Craig McAndrew, et al.. (2014). Multiple autophosphorylations significantly enhance the endoribonuclease activity of human inositol requiring enzyme 1α. BMC Biochemistry. 15(1). 3–3. 16 indexed citations
8.
Pawlyn, Charlotte, Edward S. Hookway, Peter Cain, et al.. (2014). Histone Demethylase Inhibition As a Novel Therapeutic Strategy in Myeloma. Blood. 124(21). 2087–2087. 1 indexed citations
9.
Dart, Anna, Sylvain Tollis, Michael D. Bright, Gad Frankel, & Robert G. Endres. (2012). The motor protein myosin 1G functions in FcγR-mediated phagocytosis. Journal of Cell Science. 125(24). 6020–6029. 40 indexed citations
10.
Bright, Michael D. & Gad Frankel. (2011). PAK4 phosphorylates myosin regulatory light chain and contributes to Fcγ receptor-mediated phagocytosis. The International Journal of Biochemistry & Cell Biology. 43(12). 1776–1781. 10 indexed citations
11.
Pearson, Jaclyn S., Michael D. Bright, Diana Munera, et al.. (2011). Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Molecular Microbiology. 80(6). 1420–1438. 274 indexed citations
12.
Bright, Michael D., Andrew P. Garner, & Anne J. Ridley. (2009). PAK1 and PAK2 have different roles in HGF-induced morphological responses. Cellular Signalling. 21(12). 1738–1747. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iulia A. Kovari Breakdown of academic impact, for papers by Tanusree Sengupta Breakdown of academic impact, for papers by Cecelia L. Green Breakdown of academic impact, for papers by Ismael Secundino Breakdown of academic impact, for papers by H Furukawa Breakdown of academic impact, for papers by Peter Conradt Breakdown of academic impact, for papers by Momka Bratoeva Breakdown of academic impact, for papers by Sang Won Hyun Breakdown of academic impact, for papers by E Li Breakdown of academic impact, for papers by Emanuel Smeds
Rankless by CCL
2026